Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Nov 21, 2022--
The "South America Human Papillomavirus Vaccine Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Dosage, Age, Application, and End User" report has been added to ResearchAndMarkets.com's offering.
The South America human papillomavirus (HPV) vaccine market is expected to grow from US$ 173.52 million in 2022 to US$ 239.53 million by 2028; it is estimated to grow at a CAGR of 5.5% from 2022 to 2028.
Companies are undertaking many research and development activities to introduce advanced HPV tests. For instance, in May 2021, BD, a leading medical technology company, launched the first CE-marked assay for HPV screening from at-home self-collected vaginal samples.
This allows laboratories to process self-collected samples via a BD diluent tube. At-home collection of samples will help address the urgent public health challenge of reaching out to women who do not attend routine cervical cancer screening. Further, in September 2020, drug administrations across the region approved the expanded use of F. Hoffmann-La Roche Ltd, CINtec PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV).
The CINtec PLUS Cytology test identifies the simultaneous presence of the two biomarkers - p16 and Ki-67 - in a single cell. This abnormality is associated with HPV infections that progress to pre-cancer or cancer if not treated. A positive result of these two biomarkers means the person taking the test is at a high risk of getting the disease. Such robust developments in HPV diagnostics tests are likely to reshape the market during the forecast period.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the South America human papillomavirus (HPV) vaccine market . The South America human papillomavirus (HPV) vaccine market is expected to grow at a good CAGR during the forecast period.
South America Human Papillomavirus (HPV) Vaccine Market Segmentation
Key Market Dynamics
Market Drivers
Market Restraints
Future Trends
Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/cu2hwl
View source version on businesswire.com:https://www.businesswire.com/news/home/20221121005456/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD: SOUTH AMERICA
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 11/21/2022 06:16 AM/DISC: 11/21/2022 06:16 AM
http://www.businesswire.com/news/home/20221121005456/en